Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
Status:
Completed
Trial end date:
2016-07-13
Target enrollment:
Participant gender:
Summary
This study aims to determine whether the Cogstate testing battery can detect improvements in
cognitive function in participants with mild AD. The primary hypothesis is that for one of
the Cogstate battery tests, One Card Learning (OCL), the standard deviation associated with
the change from baseline in OCL measurements after 12 weeks of donepezil and placebo
treatments is =<0.1